Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102285896B details a novel chloramphenicol synthesis using benzaldehyde, offering high purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Novel chiral catalytic route for tenofovir analogs offering high enantioselectivity and cost efficiency for global pharmaceutical supply chains and manufacturing partners.
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN109503656A reveals a cesium carbonate catalyzed route for high-purity chiral organophosphonates. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105732568A offers safer chiral intermediate synthesis. Reduces toxic reagents and improves scalability for pharmaceutical manufacturing supply chains globally.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN103788069B reveals advanced asymmetric oxidation for esomeprazole magnesium trihydrate. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109748883B details a metal-free asymmetric ring-opening method for high-purity chiral beta-amino derivatives, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Offers mild conditions and high enantioselectivity for reliable supply chain integration.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis method for N-N axis chiral compounds offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis. Enables cost reduction and supply chain reliability for anticancer intermediates.
Novel chiral phase transfer catalysis enables high-purity indole derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediate supply chains globally.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Patent CN116768904B reveals high-yield chiral synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN101735134A details a high-yield enantioselective cyclization method. Offers cost-effective routes for optically pure tetrahydropyrrole drugs.